| Oct 8 |
Precipio Expands Bloodhound™ MPN Panel by Adding CALR Mutation Subtyping
|
| Sep 6 |
Precipio Announces Employee Stock Option Plan Repricing
|
| Sep 5 |
Zacks Initiates Coverage of Precipio With Outperform Recommendation
|
| Aug 19 |
Precipio, Inc. (PRPO) Q2 2024 Earnings Call Transcript
|
| Aug 15 |
Precipio Announces Q2-2024 Shareholder Update Call
|
| Jul 25 |
Precipio Reports $0.3M cash generated by operations (unaudited) in Q2-2024, as the company advances towards breakeven
|
| Jul 17 |
Precipio Reports $4.4M for Q2-2024 (unaudited) Revenues, a leap of 30% from Q1-2024
|
| Jun 13 |
Precipio Inc. Announces Adjournment of Annual Meeting of Stockholders
|
| Jun 12 |
Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting
|
| Jun 12 |
Precipio Provides Status Update on Current Business Matters
|
